Patent Grant
9387061
This disclosure relates generally to medical devices and more particularly to implants configured to provide support within a pelvic region of a patient.
A variety of medical procedures are performed to treat various female pelvic dysfunctions, including procedures to treat urinary incontinence, and correcting various prolapse conditions such as uterine prolapse, cystoceles, rectoceles, and vaginal vault prolapse.
Women often experience vaginal prolapses due to age or other factors. For example, women may experience a cystocele, a rectocele and/or a hysterocele. A hysterocele occurs when the uterus descends into the vagina, and a rectocele occurs when the rectum bulges into the vagina. Treatments of such dysfunctions have included suturing procedures or the use of implants for support or suspension.
A hysterocele is often treated with a hysterectomy followed by a vaginal vault suspension. Various known devices and procedures are used to deliver and secure pelvic implants within a variety of different anatomical structures within a pelvic region to perform the vaginal vault suspension. Existing implants differ in many ways including size, shape, material, number and location of straps, and in the method in which they are delivered and placed within a pelvic region.
Complications and difficulties may occur during known vaginal vault procedures. Additionally, some known implants may not provide adequate support to the pelvic region. Thus, it would be desirable to provide improved pelvic implants and methods for performing vaginal vault suspension procedures.
In one embodiment, an implant is configured to be placed within a body of a patient. The implant includes a support member. The support member is configured to be placed adjacent a vaginal apex of a patient. The support member has a length sufficient to extend the length of the vaginal apex but not of a length sufficient to extend from the vaginal apex to a location between a vagina of the patient and a rectum of the patient. The implant also includes first and second arm members coupled to the support member. The arm members are configured to be coupled to bodily tissue of the patient to help secure the implant within the body of the patient.
The devices and methods described herein are generally directed to implants and the delivery and placement of such implants within a pelvic region (also referred to herein as “pelvis”) of a patient.
Various embodiments of implants are described herein. An implant can be delivered to a pelvic region of a patient using a variety of different delivery devices, only some examples of which are described herein.
Various delivery aids are also described, some of which can be included as part of an implant (e.g., provided to a physician assembled) some of which can be assembled to an implant just prior to implantation. Such delivery aids are typically removed after placing one or more straps of an implant at a desired tissue securement location, leaving the strap to engage the tissue and support the support portion of the implant. For example, a sleeve or dilator assembly can be used to lead an implant or a strap of an implant through a tissue in an intracorporeal location (i.e., within the patient's body), such as the sacrospinous ligament or arcus tendineus. In other embodiments, a sleeve or dilator assembly can be used to lead an implant or a strap of an implant through a tissue and to an extracorporeal location (outside the patient's body), such as through an obturator membrane or muscle and out through an exterior incision in the patient.
As used herein, the terms proximal portion or proximal end refer to the portion or end, respectively, of a device that is closest to a physician when performing a medical procedure, and the terms distal portion or distal end refer to the portion or end, respectively, of the device that is furthest from the physician during a medical procedure. For example, a distal end or portion of a sleeve assembly or dilator device as described herein refers to the end or portion of the device that is first inserted into a body of a patient during a medical procedure. The proximal end or portion is the end or portion of the device that is inserted into a body of the patient after the distal end or distal portion. The terms “trailing end” and “leading end” are also referred to herein and have similar meanings as proximal and distal, respectively. As used herein, the term “leading end” refers to the end of a device or apparatus that is inserted into a body first. The term “trailing end” refers to the end of the device or apparatus that is inserted into the body after the leading end.
In the illustrated embodiment, the support member 110 includes an anterior portion 112 and a posterior portion 114. The anterior portion 112 of the support member 110 is configured to be disposed in an anterior compartment of a patient when the implant is placed within the body of the patient. The term “anterior compartment” is used herein to mean an area in the pelvic region located anteriorly of the vaginal apex of the patient (i.e., on the anterior side of the vaginal apex of the patient). In other words, in some embodiments, the anterior compartment is located adjacent an anterior wall of the vagina of the patient.
The posterior portion 112 of the support member 110 is configured to be disposed in posterior compartment of a patient when the implant 100 is placed within the body of the patient. The term “posterior compartment” is used herein to mean an area in the pelvic region located posteriorly of the vaginal apex of the patient (i.e., on the posterior side of the vaginal apex of the patient). In other words, in some embodiments, the posterior compartment is located adjacent a posterior wall of the vagina of the patient.
In some embodiments, the support member 110 is configured to be disposed adjacent to a vaginal apex of the patient when the implant is placed within the body of the patient. Accordingly, in such embodiments, the implant 100 is configured to provide support to the vaginal apex of the patient.
In some embodiments, the support member 110 is configured to be disposed adjacent to a vaginal apex of the patent and is not configured to be disposed between the rectum of the patient and the vagina of the patient. In some embodiments, the support member 110 is configured to span the length of the vaginal apex. Accordingly, in some embodiments, the support member 110 is configured to provide support to the vaginal apex region of the patient but is not configured to provide support to the area adjacent the rectum of the patient. In other words, in such embodiments, the implant 100 is not configured to repair a rectocele. Accordingly, in such embodiments, the implant 100 is not configured to support the rectum or otherwise help prevent the rectum from descending into the vagina of a patient. Additionally, in some embodiments, the implant 100 is not configured to support the bladder of the patient or otherwise prevent the bladder of the patient from descending into the vagina of the patient.
In some embodiments, the support member 110 is of a length L that is sufficient for the support member to be disposed in the anterior compartment of the patient and to be disposed adjacent the vaginal apex of the patient but is insufficient to extend to a location between the rectum of the patient and the vagina of the patient. In other words, the distance between a location in the anterior compartment of a patient and a location between a rectum and a vagina of a patient is greater than then length L of the support member 110. For example, in some embodiments the length of the support member 110 is between 6 and 15 cm. In other embodiments, the length of the support member 110 is less than 6 cm. In yet further embodiments, the length of the support member is greater than 15 cm.
In some embodiments, the posterior portion 114 of the support member 110 is of a length PL that is sufficient to be disposed within the posterior compartment of the patient and adjacent the vaginal apex of the patient but is insufficient to extend to a location between the rectum of the patient and the vagina of the patient. In other words, the distance between the vaginal apex of a patient and a location between a rectum and a vagina of a patient is greater than then length PL of the posterior portion 114 of the support member 110. For example, in some embodiments the length of the posterior portion 114 of the support member 110 is between 3 and 8 cm. In other embodiments, the length of the posterior portion 114 is less than 3 cm. In yet further embodiments, the length of the posterior portion 114 is greater than 8 cm.
The arm members 120 and 150 are coupled to the support member 110 and are configured to be coupled to bodily tissue to help secure the implant 100 in place within the body of the patient. The arm members 120 and 150 can be of any shape or size suitable for extending between the support member 110 and the bodily tissue and coupling to the bodily tissue. Although two arm members are illustrated the implant 100 may include any number of arm members. For example, in some embodiments, the implant 100 includes a single arm member. In other embodiments, the implant 100 includes more than two arm members. In some embodiments, the implant 100 includes exactly two arm members.
In some embodiments, the arm members 120 and 150 are configured to be disposed within and coupled to a sacrospinous ligament of the patient. In other embodiments, the arm members 120 and 150 are configured to be coupled to other bodily tissue.
In some embodiments, the arm members 120 and 150 include tangs configured to help anchor the arm members 120 and 150 within the bodily tissue of the patient. The terms “tanged” or “tangs” as used herein mean roughened or jagged edges or areas, such as can result from cutting a woven or knit mesh material. In other embodiments, the arm members 120 and 150 include barbs, dimples and/or other protrusions configured to engage the bodily tissue of the patient to help retain the implant 100 in place within the body of the patient. In other embodiments, other mechanisms may be used to couple the arm members 120 and 150 to the bodily tissue. For example, in one embodiment the arm members 120 and 150 may be sewn with sutures to the bodily tissue.
The support member 110 and/or the arm members 120 and 150 can each be formed with a mesh material to allow tissue in-growth to the implant 100 after implantation. For example, some or all of the implant 100 can be formed with a mesh material as described in U.S. Patent Pub. 2005/0038452 A1 to Chu, the entirety of which is hereby incorporated by reference. In some embodiments, some or all of an implant 100 can be formed with the Advantage™ Mesh or the Polyform™ Synthetic Mesh material each provided by Boston Scientific Corporation.
The implant 100 can be monolithically formed or alternatively, the implant 100 can be formed with multiple different materials and/or can include multiple different components or portions coupled together. In some embodiments, the implant can be formed with a combination of materials including synthetic and biological materials. For example, the support member 110 can be formed with a first biocompatible material and the arm members 120 and 150 can be formed with a second biocompatible material different than the first material. In other embodiments, the support member 110 is formed with a biological material, and the arm members 120 and 150 are formed with a synthetic material. In some embodiments, the arm members 120 and 150 and the support member 110 have a different weave, knit, pitch, texture, color, and pattern from each other.
In some embodiments, the arm members 120 and 150 are formed monolithically with the support member 110. In other embodiments, the arm members 120 and 150 are formed separate from the support member 110 and can be coupled to the support member 110. In such embodiments, the arm members 120 and 150 and the support member 110 can be coupled in an abutting relationship, an overlapping relationship, or can be bridged. The arm members 120 and 150 can be coupled to the support member by, for example, heat bonding, gluing, using fasteners, and/or sewing. In some embodiments, an arm member can include a heat seal along its length or a portion of its length to help prevent or reduce stretching of the arm member.
The implant 100 may be placed within the body of a patient using a number of different methods. In some embodiments, the implant 100 may be placed within the body of the patient by making a single vaginal incision.
For example, in one embodiment, the implant 100 is placed or implanted within the body of a patient by making an incision in an anterior wall of the vagina. The implant 100 may be inserted into the body of the patient through the anterior vaginal incision. The arm members 120 and 150 may then be coupled to sacrospinous ligaments of the patient. The support member 110 may be positioned within the body of the patient such that the support member 110 is disposed adjacent the vaginal apex of the patient. For example, the support member 110 may be positioned such that the anterior portion 112 of the support member 110 is disposed within an anterior compartment of the patient and the posterior portion 114 of the support member 110 is disposed within a posterior compartment of the patient. In one embodiment, the posterior portion 114 of the support member 110 is positioned within a posterior compartment of the patient through the anterior vaginal incision. In other words, the posterior portion 114 of the support member 110 is positioned without making a second vaginal incision (such as an incision in an anterior wall of the vagina of the patient). In some embodiments, the support member 110 is positioned such that it is disposed adjacent the vaginal apex of the patent, but not disposed between the rectum and vagina of the patient.
In some embodiments, the support member 110 is coupled to the vaginal apex of the patient. For example, in one embodiment, the support member 110 is stitched or sewn to the vaginal apex.
In the illustrated embodiment, the support member 210 includes an anterior portion 212 and a posterior portion 214. The anterior portion 212 of the support member 210 is configured to be disposed in an anterior compartment of a patient when the implant is placed within the body of the patient. The posterior portion 212 of the support member 210 is configured to be disposed in posterior compartment of a patient when the implant 200 is placed within the body of the patient.
In the illustrated embodiment, the support member 210 includes end portions 216 and 218. The end portions 216 and 218 each include rounded portions. The support member 210 also includes middle portion 219 that is narrower than the other portions of the support member 210. In some embodiments, the narrow middle portion 219 helps allows the implant 210 to be placed within the body of the patient without folding or kinking.
In the illustrated embodiment, the support member 210 includes side portion 217 and 219. The arm members 210 and 250 extend from the side portions 217 and 219, respectively. In the illustrated embodiments, the arm members 210 and 250 extend from the side portions 217 and 219 and are angled toward the posterior portion 214 of the support member 210.
In the illustrated embodiment, the anterior portion 212 of the support member 210 has a width that is greater than the width of the posterior portion 214 of the support member 210.
In some embodiments, the support member 210 is configured to be disposed adjacent to a vaginal apex of the patient when the implant is placed within the body of the patient. Accordingly, in such embodiments, the implant 200 is configured to provide support to the vaginal apex of the patient.
The support member 210 is configured to be disposed adjacent to a vaginal apex of the patent and not disposed between the rectum of the patient and the vagina of the patient when the support member 210 is placed within the body of the patient. In such embodiments, the support member 210 is configured to provide support to the vaginal apex region of the patient but is not configured to provide support to the area adjacent the rectum of the patient. In other words, in such embodiments, the implant 200 is not configured to be disposed adjacent the rectum or to help repair a rectocele.
The support member 210 is of a length L2 that is sufficient to be disposed in the anterior compartment of the patient and adjacent the vaginal apex of the patient but is insufficient to extend to a location between the rectum of the patient and the vagina of the patient. For example, in the illustrated embodiment, the length of the support member 210 is between 6 and 15 cm. In other words, the distance between a location in the anterior compartment of the patient and a location between a rectum and a vagina of a patient is greater than then length L2 of the support member 210.
The posterior portion 214 of the support member 210 is of a length PL2 that is sufficient to be disposed within the posterior compartment of the patient and adjacent the vaginal apex of the patient but is insufficient to extend to a location between the rectum of the patient and the vagina of the patient. In the illustrated embodiment, the length of the posterior portion 214 of the support member 210 is between 3 and 8 cm. In other words, the distance between the vaginal apex of a patient and a location between a rectum and a vagina of a patient is greater than then length PL2 of the posterior portion 214 of the support member 210.
The arm members 220 and 250 extend from the support member 210 and are configured to be coupled to bodily tissue to help secure the implant 200 in place within the body of the patient. The arm members 220 and 250 can be of any shape or size suitable for extending between the support member 210 and the bodily tissue and coupling to the bodily tissue.
In the illustrated embodiment, the arm members 220 and 250 are configured to be disposed within and coupled to a sacrospinous ligament of the patient. In the illustrated embodiment, the arm members 220 and 250 include tangs 222 and 252, respectively. The tangs 222 and 252 are configured to help anchor the arm members 220 and 250 within the bodily tissue of the patient.
The support member 210 and the arm members 220 and 250 are monolithically formed of a mesh material. The mesh material is configured to allow tissue in-growth to the implant 200 after implantation.
The delivery assembly includes a sleeve 262 disposed over the arm member 220. A dilator 264 defining a lumen is coupled to the first sleeve 262 by, for example, crimping, heat sealing, stitching, stretching, tip tipping, etc. Alternatively, the sleeve can be formed to include a portion that forms a tapered dilator. The dilator 264 can be used to expand or enlarge a passage during insertion through bodily tissue, to ease the transition to a cross-section or size of the first sleeve 262. In some embodiments, the sleeve 262 is also tapered, which also helps provide a lead-in through the bodily tissue.
The sleeve 262 is secured to the arm member 220 with a suture 266. The suture 266 is looped through the arm member 220. In this embodiment, the suture 266 is weaved or threaded through the arm member 220. For example, as shown in
The suture 262 can alternatively be coupled to the arm member 220 by, for example, crimping, heat sealing, stitching, stretching, tip tipping, etc. In some embodiments, a suture can be threaded to or secured to the arm member, for example by knotting.
The suture 266 includes a leader portion 268 that extends distally from the leading end 265 of the dilator 264. Alternatively, a separate suture can be coupled to and extend distally from the dilator. A needle 270 is coupled to a distal end of the leader portion 268 of the first suture 266. The needle 268 can be used to associate the implant 200 to a delivery device, as will be described in more detail below.
The sleeve 262 includes a separator 263 disposed between two strands of the suture 266 and near a distal end of the sleeve 262. The separator 263 maintains separation of the strands of the suture 266 within the sleeve 262. The separation of the strands of the suture 266 enables or helps facilitate a cut to be made through only a single strand of the suture 266 at, for example, location C or D, during removal of the sleeve 262 and the delivery assembly 260, as described in more detail below. In the illustrated embodiment, the separator 263 is a seal, which can be formed, for example, by heat stamping two sides of the sleeve 262 together. Other types of separators can alternatively be used, such as for example, a separate component coupled within the sleeve, or an adhesive can be used to couple the two sides of the sleeve together at a location between the strands.
The dilator 264 tapers from a first diameter at a trailing end 267 to a second, smaller diameter at a leading end 265. The first diameter can be, for example, between about 0.2 and 0.5 cm (0.08 to 0.2 inches) and the second diameter can be, for example, between about 0.03 to 0.2 cm (0.01 to 0.08 inches). For example, in some embodiments, the first diameter can be about 0.37 cm (0.15 inches) and the corresponding second diameter can be 0.03 cm (0.01 inches). The dilator 264 can be formed, for example, by molding, extruding, casting, sintering, forging, machining, or other known methods of manufacturing such medical devices.
In some embodiments, the implant 200 can be delivered into a pelvic region of a patient through a vaginal incision (e.g., a transvaginal approach). An incision can be made, for example, along an anterior vaginal mucosa. The incision can be, for example, 4 cm to 6 cm (1.57 to 2.36 inches) in length and can extend approximately 2 cm to 3 cm (0.79 inches to 1.18 inches) to the meatus. The vaginal epithelium is dissected from the underlying periurethral fascia toward the sacrospinous ligament SSL. Specifically, the anterior vaginal wall is opened and the endopelvic connective tissue is separated from the pubic ramus at the level of the bladder neck to the ischial spine, exposing the paravesical and pararectal space. The sacrospinous ligament SSL is identified and isolated through this defect. The anterior incision to place the implant 200 is about 4 cm long extending about 1 cm from the vaginal apex to the level of the proximal urethra. The incision is also known to be an anterior corporaphy incision. Variations in the incision can depend, for example, on the size of the implant 200, the needed repair or disease state to be treated, and/or the location of the intended placement of the implant 200.
The arm members 220 and 250 of the implant 210 can each be delivered through the sacrospinous ligament SSL using a suturing device. For example, a Capio® suturing device as sold by Boston Scientific may be used. In other embodiments, other suturing devices may be used.
In the illustrated embodiment, a suturing delivery device 290, as shown in
After the arm members 220 and 250 are disposed within the sacrospinous ligament SSL the arm members 220 and 250 can be adjusted to position and tension the support member 210 with the body of the patient. Each arm member 220 and 250 can be delivered sequentially using the same delivery device, or separate delivery devices can be used for some or all of the arm members. The arm members 220 and 250 (with sleeves) can be tensioned using visual guidance as the user observes the positioning of the support member 210 for the correct tension through the vaginal incision.
After the arm members 220 and 250 have been placed through the sacrospinous ligament SSL and adjusted as described above, the delivery assemblies can be removed from the arm members 220 and 250. For example, as shown in
After the arm members 220 and 250 are secured within the sacrospinous ligament SSL, excess portions of the arm members 220 and 250 can be trimmed as needed. For example, if a portion of the arm member 220 extends through the sacrospinous ligament SSL after the arm members 220 and 250 are placed within the sacrospinous ligament SSL, the portion of the arm member 220 extending through the sacrospinous ligament SSL can be removed.
In other embodiments, the arm members 220 and 250 can be secured within a pelvic region at various different tissue sites. For example, the arm members of the implant can be placed, for example, in a sacrospinous ligament SSL or coccygeus muscle. In other embodiments, the arm members are placed through, endopelvic fascia, or through tissue or ligaments near or in the pubococcygeus muscle, puborectalis muscle, distal tendineus arch of levator ani muscle or other tissue locations within a pelvic region. In still other embodiments, the straps are placed, for example, within an illiococcygeus muscle, or an arcus tendineus.
In some embodiments, a portion of the support member 210 is separately attached to a tissue within the pelvic region. Said another way, a portion of the support member 210 can be secured by means additional to the arm member 220 and 250. For example, a suture can be threaded through the support member 210 and attached to adjacent pelvic tissue, such as the vaginal apex. This can provide additional support for the support member 210.
In the illustrated embodiment, the support member 310 includes an anterior portion 312 and a posterior portion 314. The anterior portion 312 of the support member 310 is configured to be disposed in an anterior compartment of a patient when the implant is placed within the body of the patient. The posterior portion 312 of the support member 310 is configured to be disposed in posterior compartment of a patient when the implant 300 is placed within the body of the patient.
In the illustrated embodiment, the support member 310 includes end portions 316 and 318. The end portions 316 and 318 each include rounded portions. The support member also includes side portions 317 and 319. The arm members 320 and 350 extend from the side portions 317 and 319, respectively.
In the illustrated embodiment, the support member 410 includes an anterior portion 412 and a posterior portion 414. The anterior portion 412 of the support member 410 is configured to be disposed in an anterior compartment of a patient when the implant is placed within the body of the patient. The posterior portion 414 of the support member 410 is configured to be disposed in posterior compartment of a patient when the implant 400 is placed within the body of the patient.
The support member 410 includes end portions 416 and 418. End portion 418 includes a linear edge.
In the illustrated embodiment, the support member 510 includes an anterior portion 512 and a posterior portion 514. The anterior portion 512 of the support member 510 is configured to be disposed in an anterior compartment of a patient when the implant is placed within the body of the patient. The posterior portion 512 of the support member 510 is configured to be disposed in posterior compartment of a patient when the implant 500 is placed within the body of the patient.
At step 630, the implant may then be positioned within the pelvic region of the patient. In some embodiments, the implant is positioned such that an anterior portion of the implant is disposed in an anterior compartment of the pelvic region of the patient and a posterior portion of the implant is disposed in a posterior compartment of the pelvic region of the patient. In some embodiments, the implant is positioned such that no portion of the implant is disposed between a rectum of the patient and the vagina of the patient. In some embodiments, the implant is not configured to repair a rectocele (i.e., the implant is not configured to support the rectum of the patient). In some embodiments, the implant is positioned such that no portion of the implant is disposed between the bladder and the vagina. In some embodiments, the implant is not configured to repair a cystocele (i.e., the implant is not configured to support the bladder of the patient). In some embodiments, the implant is positioned through the anterior incision and no additional vaginal incisions are made. In other words, the posterior portion of the implant is positioned in the posterior compartment of the patient by pushing or otherwise placing the posterior portion of the implant into the posterior compartment from the anterior vaginal incision.
At step 640, the implant is coupled to bodily tissue. In some embodiments, arm members of the implant are coupled to sacrospinous ligaments of the patient. In some embodiments, the support member is coupled to bodily tissue, such as by stitching or sewing the support member to the bodily tissue. For example, in some embodiments, arm members of the implant are coupled to the sacrospinous ligament of the patient and the support member is stitched to the vaginal apex of the patient.
In some embodiments, an implant configured to be placed within a body of a patient, comprises a support member, a first arm member, and a second arm member. The support member is configured to be placed adjacent a vaginal apex of a patient. The support member is of a length sufficient to extend the length of the vaginal apex and of a length insufficient to extend from the vaginal apex to a location between a vagina of the patient and a rectum of the patient. The first arm member is coupled to the support member and is configured to be coupled to bodily tissue of the patient to help secure the implant within the body of the patient. The second arm member is coupled to the support member and is configured to be coupled to bodily tissue of the patient to help secure the implant within the body of the patient.
In some embodiments, the first arm member is configured to be coupled to a sacrospinous ligament of the patient. In some embodiments, the first arm member and the second arm member are each configured be coupled to a sacrospinous ligament of the patient. In some embodiments, the support member includes an anterior portion and a posterior portion. The anterior portion is configured to be placed in an anterior compartment of the patient. The posterior portion is configured to be placed in a posterior compartment of the patient.
In some embodiments, the first arm member is formed of a mesh material and includes tangs configured to help secure the arm member to the bodily tissue. In some embodiments, the support member includes a first end and a second end, the first end includes a curved section, the second end includes a curved section. In some embodiments, the support member includes an anterior portion and a posterior portion. The anterior portion has a width that is greater than then width of the posterior portion.
In some embodiments, the support member includes an anterior portion and a posterior portion. The posterior portion has a first portion and a second portion. The first portion is disposed between the second portion and the anterior portion of the support member. The first portion having a width that is shorter than a width of the second portion.
In some embodiments, an implant configured to be placed within a body of a patient, comprises a support member, a first arm member, and a second arm member. The support member is configured to be placed adjacent a vaginal apex of a patient. The support member includes an anterior portion and a posterior portion. The anterior portion is configured to be placed in an anterior compartment of the patient. The posterior portion is configured to be placed in a posterior compartment of the patient. The posterior portion has a length that is shorter than the distance between the vaginal apex and a location between a rectum of the patient and a vagina of the patient. The first arm member is coupled to the support member and is configured to be coupled to bodily tissue of a patient to help secure the implant within the body of the patient. The second arm member is coupled to the support member and is configured to be coupled to bodily tissue of a patient to help secure the implant within the body of the patient.
In some embodiments, the first arm member and the second arm member each extend from a side portion of the support member. In some embodiments, the first arm member is configured to be coupled to a sacrospinous ligament of the patient. In some embodiments, the support member and the first arm member are unitarily formed. In some embodiments, the support member, the first arm member, and the second arm member are unitarily formed of a mesh material.
In some embodiments, a method of placing an implant within a body of a patient, comprises making an incision in an anterior vaginal wall of the patient; inserting the implant through the incision and into an anterior compartment of the patient, the implant including a support member and an arm member, the support member having an anterior portion and a posterior portion; positioning the implant through the incision in the anterior vaginal wall of the patient such that the anterior portion of the support member is disposed in an anterior compartment of the patient and the posterior portion of the support member is disposed in a posterior compartment of the patient and at a location spaced from a rectum of the patient; and coupling the arm member of the implant to a sacrospinous ligament of the patient.
In some embodiments, the method includes associating the arm member with an insertion device. In some embodiments, the positioning includes positioning the implant such that the posterior portion of the support member is disposed within the posterior compartment of the patient without making a posterior vaginal incision. In some embodiments, the positioning includes positioning the support member such that the support member is adjacent a vaginal apex of the patient, but does not extend to a location between a rectum of the patient and a vagina of the patient.
In some embodiments, the coupling includes coupling the arm member to a sacrospinous ligament of the patient. In some embodiments, the method includes coupling the support member to a vaginal apex of the patient. In some embodiments, the arm member is a first arm member, the implant includes a second arm member, and the method further comprises coupling the second arm member to bodily tissue of the patient.
While certain features of the described implementations have been illustrated as described herein, many modifications, substitutions, changes and equivalents will now occur to those skilled in the art. It is, therefore, to be understood that the claims are intended to cover all such modifications and changes as fall within the scope of the embodiments.
This application is a Continuation of, and claims priority to, U.S. patent application Ser. No. 13/218,840, filed on Aug. 26, 2011, entitled “PELVIC IMPLANTS AND METHODS OF IMPLANTING THE SAME”, which, in turn, claims priority to U.S. Patent Application No. 61/379,565, filed on Sep. 2, 2010, entitled “PELVIC IMPLANTS AND METHODS OF IMPLANTING THE SAME,” the disclosures of which are incorporated by reference herein in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 669034 | Manly | Feb 1901 | A |
| 2687131 | Raiche | Aug 1954 | A |
| 3123077 | Alcamo | Mar 1964 | A |
| 4083369 | Sinnreich | Apr 1978 | A |
| 4324331 | Ignasiak | Apr 1982 | A |
| 4792336 | Hlavacek et al. | Dec 1988 | A |
| 4919667 | Richmond | Apr 1990 | A |
| 4979956 | Silvestrini | Dec 1990 | A |
| 4998912 | Scarbrough et al. | Mar 1991 | A |
| 5013292 | Lemay | May 1991 | A |
| 5082112 | Dunklee | Jan 1992 | A |
| 5112344 | Petros | May 1992 | A |
| 5149329 | Richardson | Sep 1992 | A |
| 5217466 | Hasson | Jun 1993 | A |
| 5217486 | Rice et al. | Jun 1993 | A |
| 5217494 | Coggins et al. | Jun 1993 | A |
| 5263969 | Phillips | Nov 1993 | A |
| 5356432 | Rutkow et al. | Oct 1994 | A |
| 5362294 | Seitzinger | Nov 1994 | A |
| 5364408 | Gordon | Nov 1994 | A |
| 5383905 | Golds et al. | Jan 1995 | A |
| 5405359 | Pierce | Apr 1995 | A |
| 5425747 | Brotz | Jun 1995 | A |
| 5451235 | Lock et al. | Sep 1995 | A |
| 5458609 | Gordon et al. | Oct 1995 | A |
| 5458636 | Brancato | Oct 1995 | A |
| 5464409 | Mohajer | Nov 1995 | A |
| 5485917 | Early | Jan 1996 | A |
| 5527341 | Gogolewski et al. | Jun 1996 | A |
| 5534008 | Acksel | Jul 1996 | A |
| 5540704 | Gordon et al. | Jul 1996 | A |
| 5562689 | Green et al. | Oct 1996 | A |
| 5569283 | Green et al. | Oct 1996 | A |
| 5575800 | Gordon | Nov 1996 | A |
| 5578044 | Gordon et al. | Nov 1996 | A |
| 5584859 | Brotz | Dec 1996 | A |
| 5611515 | Benderev et al. | Mar 1997 | A |
| 5643311 | Smith et al. | Jul 1997 | A |
| 5662664 | Gordon et al. | Sep 1997 | A |
| 5683402 | Cosgrove et al. | Nov 1997 | A |
| 5700272 | Gordon et al. | Dec 1997 | A |
| 5702397 | Goble et al. | Dec 1997 | A |
| 5713910 | Gordon et al. | Feb 1998 | A |
| 5720761 | Kaali | Feb 1998 | A |
| 5741277 | Gordon et al. | Apr 1998 | A |
| 5741279 | Gordon et al. | Apr 1998 | A |
| 5741299 | Rudt | Apr 1998 | A |
| 5840011 | Landgrebe et al. | Nov 1998 | A |
| 5871488 | Tovey et al. | Feb 1999 | A |
| 5899909 | Claren et al. | May 1999 | A |
| 5922826 | Kuze et al. | Jul 1999 | A |
| 5931855 | Buncke | Aug 1999 | A |
| 5948001 | Larsen | Sep 1999 | A |
| 5976127 | Lax | Nov 1999 | A |
| 5988549 | Hitomi et al. | Nov 1999 | A |
| 6010447 | Kardjian | Jan 2000 | A |
| 6012580 | Peters et al. | Jan 2000 | A |
| 6039686 | Kovac | Mar 2000 | A |
| 6042534 | Gellman et al. | Mar 2000 | A |
| 6042536 | Tihon et al. | Mar 2000 | A |
| 6042592 | Schmitt | Mar 2000 | A |
| 6044847 | Carter et al. | Apr 2000 | A |
| 6048351 | Gordon et al. | Apr 2000 | A |
| 6096051 | Kortenbach et al. | Aug 2000 | A |
| 6102921 | Zhu et al. | Aug 2000 | A |
| 6195646 | Grosh et al. | Feb 2001 | B1 |
| 6197036 | Tripp et al. | Mar 2001 | B1 |
| 6200330 | Benderev et al. | Mar 2001 | B1 |
| 6221005 | Bruckner et al. | Apr 2001 | B1 |
| 6224616 | Kugel | May 2001 | B1 |
| 6267772 | Mulhauser et al. | Jul 2001 | B1 |
| 6273852 | Lehe et al. | Aug 2001 | B1 |
| 6306079 | Trabucco | Oct 2001 | B1 |
| 6322492 | Kovac | Nov 2001 | B1 |
| 6328686 | Kovac | Dec 2001 | B1 |
| 6346111 | Gordon et al. | Feb 2002 | B1 |
| 6375662 | Schmitt | Apr 2002 | B1 |
| 6382214 | Raz et al. | May 2002 | B1 |
| 6406423 | Scetbon | Jun 2002 | B1 |
| 6454778 | Kortenbach | Sep 2002 | B2 |
| 6478727 | Scetbon | Nov 2002 | B2 |
| 6491703 | Ulmsten | Dec 2002 | B1 |
| 6502578 | Raz et al. | Jan 2003 | B2 |
| 6506190 | Walshe | Jan 2003 | B1 |
| 6530943 | Hoepffner et al. | Mar 2003 | B1 |
| 6544273 | Harari et al. | Apr 2003 | B1 |
| 6547800 | Foerster et al. | Apr 2003 | B2 |
| 6551329 | Kortenbach et al. | Apr 2003 | B1 |
| 6565580 | Beretta | May 2003 | B1 |
| 6575897 | Ory et al. | Jun 2003 | B1 |
| 6575998 | Beyar | Jun 2003 | B2 |
| 6582443 | Cabak et al. | Jun 2003 | B2 |
| 6592515 | Thierfelder et al. | Jul 2003 | B2 |
| 6592610 | Beyar | Jul 2003 | B2 |
| 6595911 | LoVuolo | Jul 2003 | B2 |
| 6596001 | Stormby et al. | Jul 2003 | B2 |
| 6599235 | Kovac | Jul 2003 | B2 |
| 6599310 | Leung et al. | Jul 2003 | B2 |
| 6612977 | Staskin et al. | Sep 2003 | B2 |
| 6638209 | Landgrebe | Oct 2003 | B2 |
| 6638210 | Berger | Oct 2003 | B2 |
| 6638211 | Suslian et al. | Oct 2003 | B2 |
| 6638284 | Rousseau et al. | Oct 2003 | B1 |
| 6641524 | Kovac | Nov 2003 | B2 |
| 6641525 | Rocheleau et al. | Nov 2003 | B2 |
| 6648899 | Kalinski et al. | Nov 2003 | B2 |
| 6648921 | Anderson et al. | Nov 2003 | B2 |
| 6652450 | Neisz et al. | Nov 2003 | B2 |
| 6666817 | Li | Dec 2003 | B2 |
| 6669706 | Schmitt et al. | Dec 2003 | B2 |
| 6669735 | Pelissier | Dec 2003 | B1 |
| 6673010 | Skiba et al. | Jan 2004 | B2 |
| 6691711 | Raz et al. | Feb 2004 | B2 |
| 6695855 | Gaston | Feb 2004 | B1 |
| 6702827 | Lund et al. | Mar 2004 | B1 |
| 6730110 | Harari et al. | May 2004 | B1 |
| 6746455 | Beyar et al. | Jun 2004 | B2 |
| 6752814 | Gellman et al. | Jun 2004 | B2 |
| 6755781 | Gellman | Jun 2004 | B2 |
| 6808487 | Migliari | Oct 2004 | B2 |
| 6830052 | Carter et al. | Dec 2004 | B2 |
| 6848152 | Genova et al. | Feb 2005 | B2 |
| 6872227 | Sump et al. | Mar 2005 | B2 |
| 6881184 | Zappala | Apr 2005 | B2 |
| 6890338 | Davis et al. | May 2005 | B1 |
| 6908425 | Luscombe | Jun 2005 | B2 |
| 6911003 | Anderson et al. | Jun 2005 | B2 |
| 6911034 | Nobles et al. | Jun 2005 | B2 |
| 6932759 | Kammerer et al. | Aug 2005 | B2 |
| 6936052 | Gellman et al. | Aug 2005 | B2 |
| 6936054 | Chu | Aug 2005 | B2 |
| 6936952 | Takamine | Aug 2005 | B2 |
| 6946003 | Wolowacz et al. | Sep 2005 | B1 |
| 6953428 | Gellman et al. | Oct 2005 | B2 |
| 6960160 | Browning | Nov 2005 | B2 |
| 6971986 | Staskin et al. | Dec 2005 | B2 |
| 6986780 | Rudnick et al. | Jan 2006 | B2 |
| 6991597 | Gellman et al. | Jan 2006 | B2 |
| 7011688 | Gryska et al. | Mar 2006 | B2 |
| 7025772 | Gellman et al. | Apr 2006 | B2 |
| 7048682 | Neisz et al. | May 2006 | B2 |
| 7056333 | Walshe | Jun 2006 | B2 |
| 7070556 | Anderson et al. | Jul 2006 | B2 |
| 7070558 | Gellman et al. | Jul 2006 | B2 |
| 7083568 | Neisz et al. | Aug 2006 | B2 |
| 7083637 | Tannhauser | Aug 2006 | B1 |
| 7090686 | Nobles et al. | Aug 2006 | B2 |
| 7094199 | Petros et al. | Aug 2006 | B2 |
| 7112171 | Rocheleau et al. | Sep 2006 | B2 |
| 7112210 | Ulmsten et al. | Sep 2006 | B2 |
| 7122039 | Chu | Oct 2006 | B2 |
| 7131943 | Kammerer | Nov 2006 | B2 |
| 7131944 | Jacquetin | Nov 2006 | B2 |
| 7198597 | Siegel et al. | Apr 2007 | B2 |
| 7204801 | Grocela | Apr 2007 | B2 |
| 7204802 | De Leval | Apr 2007 | B2 |
| 7223229 | Inman et al. | May 2007 | B2 |
| 7226407 | Kammerer et al. | Jun 2007 | B2 |
| 7226408 | Harai et al. | Jun 2007 | B2 |
| 7229453 | Anderson et al. | Jun 2007 | B2 |
| 7235043 | Gellman et al. | Jun 2007 | B2 |
| 7244260 | Koseki | Jul 2007 | B2 |
| 7244759 | Muller et al. | Jul 2007 | B2 |
| 7267645 | Anderson et al. | Sep 2007 | B2 |
| 7291104 | Neisz et al. | Nov 2007 | B2 |
| 7351197 | Montpetit et al. | Apr 2008 | B2 |
| 7361138 | Wagner et al. | Apr 2008 | B2 |
| 7364541 | Chu et al. | Apr 2008 | B2 |
| 7402133 | Chu et al. | Jul 2008 | B2 |
| 7413540 | Gellman et al. | Aug 2008 | B2 |
| 7527588 | Zaddem et al. | May 2009 | B2 |
| 7878970 | Goldberg | Feb 2011 | B2 |
| 8128552 | O'Donnell | Mar 2012 | B2 |
| 8911348 | Goldberg et al. | Dec 2014 | B2 |
| 9078727 | Miller | Jul 2015 | B2 |
| 20010023356 | Raz et al. | Sep 2001 | A1 |
| 20010049467 | Lehe et al. | Dec 2001 | A1 |
| 20020010457 | Duchon et al. | Jan 2002 | A1 |
| 20020028980 | Thierfelder et al. | Mar 2002 | A1 |
| 20020099259 | Anderson et al. | Jul 2002 | A1 |
| 20020128670 | Ulmsten et al. | Sep 2002 | A1 |
| 20020133236 | Rousseau | Sep 2002 | A1 |
| 20020143234 | LoVuolo | Oct 2002 | A1 |
| 20020147382 | Neisz et al. | Oct 2002 | A1 |
| 20020151909 | Gellman et al. | Oct 2002 | A1 |
| 20020156489 | Gellman et al. | Oct 2002 | A1 |
| 20030009181 | Gellman et al. | Jan 2003 | A1 |
| 20030023138 | Luscombe | Jan 2003 | A1 |
| 20030023250 | Watschke et al. | Jan 2003 | A1 |
| 20030055313 | Anderson et al. | Mar 2003 | A1 |
| 20030078604 | Walshe | Apr 2003 | A1 |
| 20030125715 | Kuehn et al. | Jul 2003 | A1 |
| 20030149334 | Ulmsten et al. | Aug 2003 | A1 |
| 20030176762 | Kammerer | Sep 2003 | A1 |
| 20030191360 | Browning | Oct 2003 | A1 |
| 20030208208 | Chu | Nov 2003 | A1 |
| 20030220538 | Jacquetin | Nov 2003 | A1 |
| 20030225424 | Benderev | Dec 2003 | A1 |
| 20030233107 | Gellman et al. | Dec 2003 | A1 |
| 20030233108 | Gellman et al. | Dec 2003 | A1 |
| 20040006353 | Bosley, Jr. et al. | Jan 2004 | A1 |
| 20040015048 | Neisz et al. | Jan 2004 | A1 |
| 20040015177 | Chu | Jan 2004 | A1 |
| 20040034372 | Chu | Feb 2004 | A1 |
| 20040039246 | Gellman et al. | Feb 2004 | A1 |
| 20040039453 | Anderson et al. | Feb 2004 | A1 |
| 20040059293 | Chu et al. | Mar 2004 | A1 |
| 20040068159 | Neisz et al. | Apr 2004 | A1 |
| 20040073234 | Chu et al. | Apr 2004 | A1 |
| 20040087970 | Chu et al. | May 2004 | A1 |
| 20040106847 | Benderev | Jun 2004 | A1 |
| 20040116944 | Chu et al. | Jun 2004 | A1 |
| 20040133217 | Watschke | Jul 2004 | A1 |
| 20040138747 | Kaladelfos | Jul 2004 | A1 |
| 20040181243 | Chu et al. | Sep 2004 | A1 |
| 20040186515 | Rosenblatt | Sep 2004 | A1 |
| 20040225181 | Chu et al. | Nov 2004 | A1 |
| 20040230206 | Gellman et al. | Nov 2004 | A1 |
| 20040231678 | Fierro | Nov 2004 | A1 |
| 20040236356 | Rioux et al. | Nov 2004 | A1 |
| 20040249397 | Delorme et al. | Dec 2004 | A1 |
| 20040249473 | Delorme et al. | Dec 2004 | A1 |
| 20050004427 | Cervigni | Jan 2005 | A1 |
| 20050004576 | Benderev | Jan 2005 | A1 |
| 20050038451 | Rao et al. | Feb 2005 | A1 |
| 20050038452 | Chu | Feb 2005 | A1 |
| 20050075660 | Chu et al. | Apr 2005 | A1 |
| 20050080317 | Merade | Apr 2005 | A1 |
| 20050090706 | Gellman et al. | Apr 2005 | A1 |
| 20050096499 | Li et al. | May 2005 | A1 |
| 20050101834 | Merade | May 2005 | A1 |
| 20050107805 | Bouffier et al. | May 2005 | A1 |
| 20050131391 | Chu et al. | Jun 2005 | A1 |
| 20050131392 | Chu et al. | Jun 2005 | A1 |
| 20050131393 | Chu et al. | Jun 2005 | A1 |
| 20050177022 | Chu et al. | Aug 2005 | A1 |
| 20050192600 | Nicolo et al. | Sep 2005 | A1 |
| 20050222589 | Chu | Oct 2005 | A1 |
| 20050222591 | Gingras et al. | Oct 2005 | A1 |
| 20050234291 | Gingras | Oct 2005 | A1 |
| 20050245787 | Cox et al. | Nov 2005 | A1 |
| 20050250977 | Montpetit et al. | Nov 2005 | A1 |
| 20050250978 | Kammerer | Nov 2005 | A1 |
| 20050256366 | Chu | Nov 2005 | A1 |
| 20050256530 | Petros | Nov 2005 | A1 |
| 20050261545 | Gellman et al. | Nov 2005 | A1 |
| 20050261547 | Bouffier | Nov 2005 | A1 |
| 20050277807 | MacLean et al. | Dec 2005 | A1 |
| 20050278037 | Delorme et al. | Dec 2005 | A1 |
| 20060015001 | Staskin et al. | Jan 2006 | A1 |
| 20060025649 | Smith et al. | Feb 2006 | A1 |
| 20060025783 | Smith et al. | Feb 2006 | A1 |
| 20060041185 | Browning | Feb 2006 | A1 |
| 20060041263 | Chu et al. | Feb 2006 | A1 |
| 20060052801 | Dreyfuss et al. | Mar 2006 | A1 |
| 20060058574 | Priewe et al. | Mar 2006 | A1 |
| 20060058575 | Zaddem et al. | Mar 2006 | A1 |
| 20060069301 | Neisz et al. | Mar 2006 | A1 |
| 20060089524 | Chu | Apr 2006 | A1 |
| 20060089525 | Mamo et al. | Apr 2006 | A1 |
| 20060122457 | Kovac et al. | Jun 2006 | A1 |
| 20060173237 | Jacquetin | Aug 2006 | A1 |
| 20060205995 | Browning | Sep 2006 | A1 |
| 20060211911 | Jao et al. | Sep 2006 | A1 |
| 20060229493 | Weiser et al. | Oct 2006 | A1 |
| 20060229596 | Weiser et al. | Oct 2006 | A1 |
| 20060264698 | Kondonis et al. | Nov 2006 | A1 |
| 20070043255 | O'Donnell | Feb 2007 | A1 |
| 20070055095 | Chu et al. | Mar 2007 | A1 |
| 20070161849 | Goldberg | Jul 2007 | A1 |
| 20070173864 | Chu | Jul 2007 | A1 |
| 20070270890 | Miller et al. | Nov 2007 | A1 |
| 20070276358 | Barzell et al. | Nov 2007 | A1 |
| 20080177132 | Alinsod et al. | Jul 2008 | A1 |
| 20080234543 | Goldwasser | Sep 2008 | A1 |
| 20090171140 | Chu | Jul 2009 | A1 |
| 20090171142 | Chu | Jul 2009 | A1 |
| 20090171143 | Chu et al. | Jul 2009 | A1 |
| 20100152530 | Timmer et al. | Jun 2010 | A1 |
| 20110098527 | Goldberg | Apr 2011 | A1 |
| 20120059217 | Goldberg | Mar 2012 | A1 |
| 20130066145 | Fairneny et al. | Mar 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 10056169 | Jun 2002 | DE |
| 0088714 | Sep 1983 | EP |
| 0141589 | May 1985 | EP |
| 0299158 | Jan 1989 | EP |
| 0362146 | Apr 1990 | EP |
| 0412664 | Feb 1991 | EP |
| 0567130 | Oct 1993 | EP |
| 0774240 | May 1997 | EP |
| 1201189 | May 2002 | EP |
| 1508305 | Feb 2005 | EP |
| 1520554 | Apr 2005 | EP |
| 1609439 | Dec 2005 | EP |
| 1933786 | Jun 2008 | EP |
| 2617385 | Jul 2013 | EP |
| 1998711 | Dec 2013 | EP |
| 2785521 | May 2000 | FR |
| 2852817 | Oct 2004 | FR |
| 2852818 | Oct 2004 | FR |
| 2871365 | Dec 2005 | FR |
| 670349 | Apr 1952 | GB |
| 06114067 | Apr 1994 | JP |
| 08-033635 | Feb 1996 | JP |
| 08117239 | May 1996 | JP |
| 2003-523786 | Aug 2003 | JP |
| 2004-524836 | Aug 2004 | JP |
| 2004-526483 | Sep 2004 | JP |
| PA04008407 | Dec 2005 | MX |
| 9609796 | Apr 1996 | WO |
| 9639948 | Dec 1996 | WO |
| 9835616 | Aug 1998 | WO |
| 9835632 | Aug 1998 | WO |
| 9843545 | Oct 1998 | WO |
| 9937216 | Jul 1999 | WO |
| 0009039 | Feb 2000 | WO |
| 0074613 | Dec 2000 | WO |
| 0106951 | Feb 2001 | WO |
| 0152135 | Jul 2001 | WO |
| 0231681 | Apr 2002 | WO |
| 0232284 | Apr 2002 | WO |
| 0238079 | May 2002 | WO |
| 02058563 | Aug 2002 | WO |
| 02062237 | Aug 2002 | WO |
| 02078571 | Oct 2002 | WO |
| 03068107 | Aug 2003 | WO |
| 03073960 | Sep 2003 | WO |
| 03092546 | Nov 2003 | WO |
| 03096928 | Nov 2003 | WO |
| 03096929 | Nov 2003 | WO |
| 04001619 | Dec 2003 | WO |
| 2004012626 | Feb 2004 | WO |
| 2004016196 | Feb 2004 | WO |
| 2004045457 | Jun 2004 | WO |
| 2004091442 | Oct 2004 | WO |
| 2004091443 | Oct 2004 | WO |
| 2005051204 | Jun 2005 | WO |
| 2005122721 | Dec 2005 | WO |
| 2005122954 | Dec 2005 | WO |
| 2006015031 | Feb 2006 | WO |
| 2006046950 | May 2006 | WO |
| 2007014240 | Feb 2007 | WO |
| 2007016698 | Feb 2007 | WO |
| 2007019374 | Feb 2007 | WO |
| 2007038589 | Apr 2007 | WO |
| 2007087132 | Aug 2007 | WO |
| 2007109508 | Sep 2007 | WO |
| 2009038781 | Mar 2009 | WO |
| 2009102945 | Aug 2009 | WO |
| 2010111139 | Sep 2010 | WO |
| 2012030834 | Mar 2012 | WO |
| 2012030834 | Apr 2012 | WO |
| Entry |
|---|
| Non Final Office Action for U.S. Appl. No. 13/218,840, mailed on Jun. 7, 2013, 11 pages. |
| Response to Non Final Office Action for U.S. Appl. No. 13/218,840, filed Sep. 3, 2013, 9 pages. |
| Final Office Action for U.S. Appl. No. 13/218,840, mailed on Dec. 24, 2013, 11 pages. |
| Response to Final Office Action for U.S. Appl. No. 13/218,840, filed Mar. 24, 2014, 9 pages. |
| Notice of Allowance for U.S. Appl. No. 13/218,840, mailed on May 1, 2014, 7 pages. |
| Non Final Office Action for U.S. Appl. No. 12/983,666, mailed on Oct. 6, 2011, 12 pages. |
| Response to Non Final Office Action for U.S. Appl. No. 12/983,666, filed Feb. 3, 2012, 9 pages. |
| Final Office Action for U.S. Appl. No. 12/983,666, mailed on Apr. 24, 2012, 10 pages. |
| Response to Final Office Action for U.S. Appl. No. 12/983,666, filed Jun. 25, 2012, 8 pages. |
| Advisory Action for U.S. Appl. No. 12/983,666, mailed on Jul. 13, 2012, 3 pages. |
| Non Final Office Action for U.S. Appl. No. 12/983,666, mailed on Jul. 30, 2013, 10 pages. |
| Response to Non Final Office Action for U.S. Appl. No. 12/983,666, filed Oct. 30, 2013, 8 pages. |
| Final Office Action for U.S. Appl. No. 12/983,666, mailed on May 30, 2014, 13 pages. |
| Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jan. 19, 2010, 15 pages. |
| Non Final Office Action for U.S. Appl. No. 11/686,683, mailed on Apr. 26, 2012, 17 pages. |
| Response to Non Final Office Action for U.S. Appl. No. 11/686,683, filed Aug. 27, 2012, 13 pages. |
| Final Office Action for U.S. Appl. No. 11/686,683, mailed on Nov. 5, 2012, 26 pages. |
| Response to Final Office Action for U.S. Appl. No. 11/686,683, filed Feb. 5, 2013, 14 pages. |
| Non Final Office Action for U.S. Appl. No. 11/686,683, mailed on Aug. 13, 2013, 26 pages. |
| Response to Non Final Office Action for U.S. Appl. No. 11/686,683, filed Nov. 13, 2013, 13 pages. |
| Final Office Action for U.S. Appl. No. 11/686,683, mailed on Feb. 25, 2014, 29 pages. |
| Response to Final Office Action for U.S. Appl. No. 11/686,683, filed May 23, 2014, 12 pages. |
| Non Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jun. 17, 2014, 31 pages. |
| Office Action for Japanese Patent Application No. 2009-500607, mailed on Nov. 11, 2011, 3 pages. |
| Response to Office Action for Japanese Patent Application No. 2009-500607, filed on Feb. 13, 2012, 18 pages. |
| Office Action for Japanese Patent Application No. 2009-500607, mailed on Jun. 5, 2012, 2 pages. |
| Notice of Allowance for Japanese Patent Application No. 2009-500607, mailed on Jun. 19, 2013, 3 pages. |
| Response to Office Action for Japanese Patent Application No. 2012-28740, filed on Aug. 23, 2013, 9 pages. |
| Office Action for Japanese Patent Application No. 2012-28740, mailed on Dec. 25, 2013, 7 pages. |
| Advisory Action for U.S. Appl. No. 11/331,777, mailed on Feb. 17, 2010, 3 pages. |
| Non-Final Office Action for U.S. Appl. No. 11/331,777, mailed on Dec. 6, 2013, 18 pages. |
| Response to Non-Final Office Action for U.S. Appl. No. 11/331,777, filed Mar. 6, 2014, 8 pages. |
| Final Office Action for U.S. Appl. No. 11/331,777, mailed on Apr. 14, 2014, 18 pages. |
| Office Action for U.S. Appl. No. 11/493,148, mailed on Mar. 25, 2010, 14 pages. |
| Final Office Action for U.S. Appl. No. 11/535,901, mailed on Jan. 29, 2010, 21 pages. |
| Notice of Allowance for U.S. Appl. No. 11/535,901, mailed on Sep. 21, 2010, 9 pages. |
| Office Action for Canadian Patent Application No. 2,644,983, mailed on May 26, 2014, 2 pages. |
| Response to Office Action for Canadian Patent Application No. 2,644,983, filed on Mar. 28, 2014, 28 pages. |
| Search Report for European Patent Application No. 01117717, mailed on Apr. 18, 2007, 5 pages. |
| Search Report for European Patent Application No. 05356101, mailed on Nov. 1, 2005, 2 pages. |
| Office Action for European Patent Application No. 07758616.2, mailed on Jun. 6, 2011, 5 pages. |
| Search Report or European Patent Application No. EP 90307704, mailed on Apr. 18, 2007, 1 page. |
| Office Action from European Patent Application No. 06815573.8 mailed on Nov. 15, 2013, 3 pages. |
| Response to Office Action for EP Patent Application No. 07758616.2 filed on Oct. 17, 2011, 31 pages. |
| Search report for French Patent Application No. 0303893, mailed on Jan. 21, 2004, 2 pages. |
| Search report for French Patent Application No. 0303895, mailed on Jan. 21, 2004, 3 pages. |
| Search report for French Patent Application No. 0406352, mailed on May 25, 2007, 3 pages. |
| International Search Report for PCT Application No. PCT/AU2004/001674, mailed on Dec. 21, 2004, 3 pages. |
| International Search Report for PCT Application No. PCT/FR2004/000765, mailed on Dec. 28, 2004, 10 pages. |
| International Search Report for PCT Application No. PCT/FR2004/000766, mailed on Nov. 8, 2004, 9 pages. |
| International Preliminary Report on Patentability for PCT Patent Application No. PCT/US2011/049753 mailed on Mar. 14, 2013, 9 pages. |
| International Search Report for PCT Patent Application No. PCT/US1998/03066, mailed on May 28, 1998, 2 pages. |
| International search Report for PCT Patent ApplicationNo. PCT/US2001/031234, mailed on Dec. 14, 2001, 1 page. |
| International Search Report for PCT Patent Application No. PCT/US2001/30033, mailed on May 10, 2002, 1 page. |
| International Search Report for PCT Patent Application No. PCT/US2004/035329, mailed on Jul. 6, 2005, 7 pages. |
| International Search Report for PCT Patent Application No. PCT/US2005/021267, mailed on Nov. 30, 2005, 6 pages. |
| International Search Report for PCT Patent Application No. PCT/US2006/028963, mailed on Dec. 6, 2006, 3 pages. |
| International Search Report for PCT Application Patent No. PCT/US2007/000190, mailed on Jul. 3, 2007, 5 pages. |
| International Preliminary Report on Patentability for PCT Patent Application No. PCT/US2007/000190, mailed on Jul. 24, 2008. |
| Written Opinion for PCT Patent Application No. PCT/US2007/000190, mailed on Jul. 3, 2007, 9 pages. |
| International Search Report for PCT Patent Application No. PCT/US2007/064079, mailed on Aug. 28, 2007, 4 pages. |
| International Search Report and Written Opinion for PCT Patent Application No. PCT/US2010/027985, mailed on Oct. 20, 2010, 9 pages. |
| International Search Report and Written Opinion for PCT Application PCT/US2011/049753, mailed on Mar. 6, 2012, 21 pages. |
| “Capio® CL Transvaginal Suture Capturing Device”, The Capio CL Transvaginal Suture Capturing Device allows for a transvaginal suture fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, printed on Apr. 7, 2006, 2 pages. |
| “Capio® CL Transvaginal Suture Capturing Device”, Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 4 pages. |
| “Capio® Open Access and Standard Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, printed on Apr. 7, 2006, 2 pages. |
| “Capio® RP Suture Device”, Boston Scientific, printed on Apr. 7, 2006, 1 page. |
| “Capio® Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, 2005, 4 pages. |
| “Capio CL Transvaginal Suture Capturing Device,” Designed for Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 1 page. |
| Hardiman et al, “Sacrospinous Vault Suspension and Abdonimal Colposacropexy: Success Rates and Complications”, 8 Section of Urogynecology, Department of Obstetrics and Gynecology, Sep. 18, 1995, 5 pages. |
| Leron et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology, 108.3, 2001, pp. 629-633. |
| Pohl et al., “Bilateral Transvaginal Sacrospinous Colpopexy: Preliminary Experience”, 23rd Annual Meeting of the Society of Gynecologic Surgeons, Feb. 24-26, 1997, 7 pages. |
| Shah et al., “Short-Term Outcome Analysis of Total Pelvic Reconstruction With Mesh: The Vaginal Approach”, The Journal of Urology, vol. 171, Jan. 2004, pp. 261-263. |
| Response to Final Office Action for U.S. Appl. No. 11/686,683, filed Sep. 17, 2014, 13 pages. |
| Final Office Action for U.S. Appl. No. 11/686,683, mailed on Dec. 23, 2014, 18 pages. |
| Response to Final Office Action for U.S. Appl. No. 12/983,666, filed Aug. 19, 2014, 8 pages. |
| Non-Final Office Action for U.S. Appl. No. 12/983,666, mailed on Aug. 26, 2014, 12 pages. |
| Response to Non-Final Office Action for U.S. Appl. No. 12/983,666, filed Nov. 25, 2014, 9 pages. |
| Notice of Allowance for U.S. Appl. No. 13/218,840, mailed on Aug. 15, 2014, 7 pages. |
| Notice of Allowance for U.S. Appl. No. 11/686,683, mailed on Mar. 13, 2015, 7 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20150094527 A1 | Apr 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61379565 | Sep 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13218840 | Aug 2011 | US |
| Child | 14570653 | US |
